Atlas Trials

Exploratory Study to Assess the Effect of Fampridine (BIIB041) on Walking Ability and Balance in Participants With Multiple Sclerosis.

Clinical trial NCT01597297 · COMPLETED

Trial details

NCT number
NCT01597297
Sponsor
Biogen
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Multiple Sclerosis
Start date
2012-08-01
Primary completion
2013-08-01
Enrollment
132

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.